However, they also showed that deletion of p38 Mapk14 improves the anti-cancer properties in adoptive T-cell therapy in mice and enhances the proliferation and expression of effector molecules in human T cells (Gurusamy et al, 2020). This evidence concerns the gene MAPK14 and cancer.